Successful With Research and Development
Dr. Wolff Sales Approach the 400 Million Euro Mark
The German Dr. Wolff Group achieved an annual revenue of 390.6 million euros in the fiscal year 2023. According to its preliminary figures, the company grew by 7.5 per cent over the previous year.
Products Are Developed and Purchased As Problem Solvers
According to the manufacturer, the toothpaste brand Karex, addressing chalking teeth, the Alpecin Grey Attack shampoo for gradually darker hair, as well as the gynaecological Vagisan range for a healthier intimate area played an important role in the group's financial development. They all achieved double-digit growth. As a result, the group sees itself as being equipped for the current challenges, as it aims to create products that improve the quality of life through continuous research and development.
Further Internationalisation Is Planned
New health and care products are also planned for 2024, which is why the company remains optimistic about the coming year. Nevertheless, managing partner Eduard R. Dörrenberg is cautious. The framework conditions, especially in terms of costs, the ever-increasing bureaucracy, and European overregulation, continue to make entrepreneurial activities more challenging, he says. The group wants to face the challenges, to implement the necessary changes, and also to continue to drive internationalisation,
Source: Dr. Wolff Group